Please login to the form below

Not currently logged in
Email:
Password:

Forendo Pharma

This page shows the latest Forendo Pharma news and features for those working in and with pharma, biotech and healthcare.

Organon buys Forendo in $1bn deal

Organon buys Forendo in $1bn deal

Forendo purchase bolsters Organon’s pipeline with candidates in endometriosis and polycystic ovarian syndrome. ... Our acquisition of Forendo further demonstrates our commitment to building a pipeline of impactful treatment options for women with unmet

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 335. Forendo Pharma/Apricus Biosciences. Licence [A]. Fispemifene a selective oestrogen modulator in P2 for secondary hypogonadism.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    He becomes a non-executive director. Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... Risto Lammintausta, chief executive officer of Forendo Pharma, said: “We are delighted to welcome David with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...